Owner MOCHIDA PHARMACEUTICAL CO., LTD.

Inventors NAKAMURA, Yusuke; SUGANO, Sumio; KATO, Yutaka; TAKAHASHI, Tomohiro; SHIRAKAWA, Kamon

Pub. Number AU-A-2002232214

PCT Pub. Number WO2002/064771

Priority 2001-39196 15.02.01 JP

Filing date 15 February 2002

Wipo publication date 28 August 2002

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

C12Q 001/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C07K 014/47 Peptides having more than 20 amino acids

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 001/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells